SDSU releases statement on Walgreens vaccination mistake
San Diego State University released the following statement in response to Walgreens administering vaccinations to the students at the wrong temperature.
SDSU Statement on Walgreens Vaccination Issue:
SAN DIEGO, Calif. (October 19, 2018) – Only meningococcal (MenB) vaccines given by Walgreens at San Diego State University on Oct. 5 and Oct. 8 have been impacted, resulting in the need for approximately 350 students to be re-vaccinated. Students who received a MenB vaccination through the various on-campus clinics by the County of San Diego and Kaiser Permanente have not been affected and do not need to be re-vaccinated.
SDSU has been working in collaboration with Walgreens and the County of San Diego Health and Human Services Agency (HHSA) to ensure that all SDSU student who were vaccinated by Walgreens on Oct. 5 and Oct. 8 are re-vaccinated.
Walgreens is communicating directly with all students impacted, and SDSU has begun offering support to help re-vaccinate students while also hosting space on campus for Walgreens to re-vaccinate those students.
In partnership with the HHSA , SDSU continues to hold on-campus MenB vaccination clinics. Information regarding on-campus clinics can be found online at newscenter.sdsu.edu.
There are no additional confirmed cases of MenB, and SDSU and the HHSA continue to monitor the current outbreak of MenB on campus. We continue to urge students to take the situation seriously and receive the MenB vaccine through their primary health physician, a pharmacy or an on-campus clinic as soon as possible. The shared goal of SDSU and HHSA is to ensure that all SDSU undergraduates age 23 and younger receive the full series of a MenB vaccine (Bexsero and Trumenba are the vaccines available).
Education and communications campaigns are underway to inform students in the target group about meningitis, the existing MenB vaccines and various healthy habits to protect against the spread of diseases.